GB1575904A - Phenyl piperazines - Google Patents

Phenyl piperazines Download PDF

Info

Publication number
GB1575904A
GB1575904A GB16526/76A GB1652676A GB1575904A GB 1575904 A GB1575904 A GB 1575904A GB 16526/76 A GB16526/76 A GB 16526/76A GB 1652676 A GB1652676 A GB 1652676A GB 1575904 A GB1575904 A GB 1575904A
Authority
GB
United Kingdom
Prior art keywords
formula
piperazine
phenylpiperazine
ylmethyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB16526/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Priority to GB16526/76A priority Critical patent/GB1575904A/en
Priority to ZA00771849A priority patent/ZA771849B/xx
Priority to NZ183715A priority patent/NZ183715A/xx
Priority to CA275,160A priority patent/CA1087617A/en
Priority to IE671/77A priority patent/IE44730B1/en
Priority to IL51787A priority patent/IL51787A/xx
Priority to CH455777A priority patent/CH625802A5/fr
Priority to CH525781A priority patent/CH633009A5/fr
Priority to MX775629U priority patent/MX4596E/es
Priority to PH19656A priority patent/PH14124A/en
Priority to PT66452A priority patent/PT66452B/pt
Priority to AU24386/77A priority patent/AU514822B2/en
Priority to FR7711669A priority patent/FR2348925A1/fr
Priority to GR53236A priority patent/GR64084B/el
Priority to DE19772717415 priority patent/DE2717415A1/de
Priority to OA56149A priority patent/OA05643A/xx
Priority to ES457988A priority patent/ES457988A1/es
Priority to RO7790106A priority patent/RO72831A/ro
Priority to SE7704536A priority patent/SE7704536L/xx
Priority to BG036062A priority patent/BG27746A3/xx
Priority to BG037191A priority patent/BG28055A3/xx
Priority to YU01044/77A priority patent/YU104477A/xx
Priority to DK176177A priority patent/DK176177A/da
Priority to LU77170A priority patent/LU77170A1/xx
Priority to CS772668A priority patent/CS196360B2/cs
Priority to AR267310A priority patent/AR222003A1/es
Priority to FI771287A priority patent/FI63937C/fi
Priority to BE6045977A priority patent/BE853899A/xx
Priority to AT285177A priority patent/AT355579B/de
Priority to NL7704456A priority patent/NL7704456A/xx
Priority to NO771398A priority patent/NO146710C/no
Priority to DD7700198558A priority patent/DD129790A5/xx
Priority to SU772474105A priority patent/SU664564A3/ru
Priority to PL1977197550A priority patent/PL117466B1/pl
Priority to HU77LI311A priority patent/HU176820B/hu
Priority to JP4727677A priority patent/JPS52151183A/ja
Priority to US05/813,912 priority patent/US4123529A/en
Priority to SU772558499A priority patent/SU727146A3/ru
Priority to ES467948A priority patent/ES467948A1/es
Priority to AR271519A priority patent/AR222635A1/es
Publication of GB1575904A publication Critical patent/GB1575904A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB16526/76A 1976-04-23 1976-04-23 Phenyl piperazines Expired GB1575904A (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines
ZA00771849A ZA771849B (en) 1976-04-23 1977-03-28 Phenyl piperazines
NZ183715A NZ183715A (en) 1976-04-23 1977-03-28 Phenylpiperazine derivatives
CA275,160A CA1087617A (en) 1976-04-23 1977-03-30 Phenyl piperazines
IE671/77A IE44730B1 (en) 1976-04-23 1977-03-30 Phenyl piperazines
IL51787A IL51787A (en) 1976-04-23 1977-03-30 1 heterocyclylalkyl 4 phenyl piperazine derivatives their preparation and pharmaceutical compositions containing them
CH455777A CH625802A5 (en) 1976-04-23 1977-04-13 Process for the preparation of phenylpiperazine derivatives
CH525781A CH633009A5 (en) 1976-04-23 1977-04-13 Process for the preparation of new phenylpiperazine derivatives
MX775629U MX4596E (es) 1976-04-23 1977-04-13 Procedimiento para preparar un derivado de fenilpiperazina
PH19656A PH14124A (en) 1976-04-23 1977-04-14 Phenyl piperazines
PT66452A PT66452B (en) 1976-04-23 1977-04-18 Process for preparing a phenylpiperazine
AU24386/77A AU514822B2 (en) 1976-04-23 1977-04-18 Phenyl diperazines derivatives
FR7711669A FR2348925A1 (fr) 1976-04-23 1977-04-19 Derives de phenylpiperazine
GR53236A GR64084B (en) 1976-04-23 1977-04-19 Method for the preparation of phenyl piperazines
DE19772717415 DE2717415A1 (de) 1976-04-23 1977-04-20 Verfahren zur herstellung von phenylpiperazinderivaten, phenylpiperazinderivate und diese enthaltende pharmazeutische zubereitungen
OA56149A OA05643A (fr) 1976-04-23 1977-04-20 Dérivés de phénylpipérazine.
ES457988A ES457988A1 (es) 1976-04-23 1977-04-20 Un procedimiento de preparacion de un derivado de fenilpipe-razina.
RO7790106A RO72831A (ro) 1976-04-23 1977-04-20 Procedeu pentru prepararea unor fenilpiperazine
SE7704536A SE7704536L (sv) 1976-04-23 1977-04-20 Forfarande for framstellning av fenylpiperazinderivat
BG036062A BG27746A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни
BG037191A BG28055A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни
YU01044/77A YU104477A (en) 1976-04-23 1977-04-21 Process for obtaining phenyl piperazine derivatives
DK176177A DK176177A (da) 1976-04-23 1977-04-21 Fremgangsmade til fremstilling af phenylpiperaziner
LU77170A LU77170A1 (enExample) 1976-04-23 1977-04-21
CS772668A CS196360B2 (en) 1976-04-23 1977-04-21 Process for preparing derivatives of phenylpiperazine
AR267310A AR222003A1 (es) 1976-04-23 1977-04-22 Procedimiento para la preparacion de derivados de fenilpiperazina
FI771287A FI63937C (fi) 1976-04-23 1977-04-22 Foerfarande foer framstaellning av terapeutiskt anvaendbara feylpiperaziner
BE6045977A BE853899A (fr) 1976-04-23 1977-04-22 Derives de phenylpiperazine
AT285177A AT355579B (de) 1976-04-23 1977-04-22 Verfahren zur herstellung von neuen phenyl- piperazinderivaten und deren salzen
NL7704456A NL7704456A (nl) 1976-04-23 1977-04-22 Werkwijze voor de bereiding van farmaceutisch werkzame fenylpiperazinen, werkwijze voor de bereiding van een farmaceutisch preparaat en preparaat, verkregen volgens deze werkwijze.
NO771398A NO146710C (no) 1976-04-23 1977-04-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylpiperazinderivater
DD7700198558A DD129790A5 (de) 1976-04-23 1977-04-22 Verfahren zur herstellung von phenylpiperazinderivaten
SU772474105A SU664564A3 (ru) 1976-04-23 1977-04-22 Способ получени производных фенилпиперазина или их солей
PL1977197550A PL117466B1 (en) 1976-04-23 1977-04-22 Process for preparing novel derivatives of phenylopiperazine
HU77LI311A HU176820B (en) 1976-04-23 1977-04-22 Process for preparing phenyl-piperazine derivatives
JP4727677A JPS52151183A (en) 1976-04-23 1977-04-23 Phenylpyperazine
US05/813,912 US4123529A (en) 1976-04-23 1977-07-08 Phenylpiperazine derivatives
SU772558499A SU727146A3 (ru) 1976-04-23 1977-12-28 Способ получени производных фенилпиперазина или их солей
ES467948A ES467948A1 (es) 1976-04-23 1978-03-16 Un procedimiento para la preparacion de un derivado de fe- nilpiperazina.
AR271519A AR222635A1 (es) 1976-04-23 1978-03-22 Procedimiento para la preparacion de derivados de fenilpiperazina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
GB1575904A true GB1575904A (en) 1980-10-01

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
GB16526/76A Expired GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Country Status (34)

Country Link
JP (1) JPS52151183A (enExample)
AR (2) AR222003A1 (enExample)
AT (1) AT355579B (enExample)
AU (1) AU514822B2 (enExample)
BE (1) BE853899A (enExample)
BG (2) BG27746A3 (enExample)
CA (1) CA1087617A (enExample)
CH (2) CH633009A5 (enExample)
CS (1) CS196360B2 (enExample)
DD (1) DD129790A5 (enExample)
DE (1) DE2717415A1 (enExample)
DK (1) DK176177A (enExample)
ES (2) ES457988A1 (enExample)
FI (1) FI63937C (enExample)
FR (1) FR2348925A1 (enExample)
GB (1) GB1575904A (enExample)
GR (1) GR64084B (enExample)
HU (1) HU176820B (enExample)
IE (1) IE44730B1 (enExample)
IL (1) IL51787A (enExample)
LU (1) LU77170A1 (enExample)
MX (1) MX4596E (enExample)
NL (1) NL7704456A (enExample)
NO (1) NO146710C (enExample)
NZ (1) NZ183715A (enExample)
OA (1) OA05643A (enExample)
PH (1) PH14124A (enExample)
PL (1) PL117466B1 (enExample)
PT (1) PT66452B (enExample)
RO (1) RO72831A (enExample)
SE (1) SE7704536L (enExample)
SU (2) SU664564A3 (enExample)
YU (1) YU104477A (enExample)
ZA (1) ZA771849B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007100852A1 (en) * 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Therapeutic piperazines as pde4 inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
KR970701705A (ko) * 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ 수용체 효능제, 신규한 티아졸 유도체 및 이의 중간체(5-HT₃receptor agonist, novel thiazole derivative, and intermediate therefor)
CA2144669A1 (en) * 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DZ3292A1 (fr) * 2001-09-13 2005-05-14 Solvay Pharm Gmbh Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposes

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007100852A1 (en) * 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Therapeutic piperazines as pde4 inhibitors
US7829713B2 (en) 2006-02-28 2010-11-09 Helicon Therapeutics, Inc. Therapeutic piperazines
US8338405B2 (en) 2006-02-28 2012-12-25 Dart Neuroscience Llc Therapeutic piperazines
AU2007221021B2 (en) * 2006-02-28 2013-01-17 Dart Neuroscience (Cayman) Ltd Therapeutic piperazines as PDE4 inhibitors
US8501745B2 (en) 2006-02-28 2013-08-06 Dart Neuroscience (Cayman) Ltd. Piperazine PDE4 inhibitors and uses thereof
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
US9624200B2 (en) 2006-02-28 2017-04-18 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
IL51787A0 (en) 1977-05-31
PT66452B (en) 1979-03-09
AR222635A1 (es) 1981-06-15
CA1087617A (en) 1980-10-14
SU664564A3 (ru) 1979-05-25
SE7704536L (sv) 1977-10-24
DK176177A (da) 1977-10-24
ZA771849B (en) 1978-11-29
BG27746A3 (bg) 1979-12-12
ATA285177A (de) 1979-08-15
GR64084B (en) 1980-01-21
DE2717415A1 (de) 1977-11-10
CH625802A5 (en) 1981-10-15
BE853899A (fr) 1977-10-24
PL197550A1 (pl) 1979-05-21
IE44730B1 (en) 1982-03-10
PH14124A (en) 1981-02-26
NL7704456A (nl) 1977-10-25
CH633009A5 (en) 1982-11-15
ES457988A1 (es) 1978-07-16
NO146710B (no) 1982-08-16
DD129790A5 (de) 1978-02-08
FI771287A7 (enExample) 1977-10-24
IE44730L (en) 1977-10-23
CS196360B2 (en) 1980-03-31
RO72831B (ro) 1983-07-30
NO771398L (no) 1977-10-25
IL51787A (en) 1980-02-29
ES467948A1 (es) 1978-11-01
LU77170A1 (enExample) 1979-01-18
SU727146A3 (ru) 1980-04-05
MX4596E (es) 1982-06-25
AU514822B2 (en) 1981-02-26
NO146710C (no) 1982-11-24
HU176820B (en) 1981-05-28
BG28055A3 (bg) 1980-02-25
AU2438677A (en) 1978-10-26
AT355579B (de) 1980-03-10
AR222003A1 (es) 1981-04-15
JPS52151183A (en) 1977-12-15
PT66452A (en) 1977-05-01
NZ183715A (en) 1980-04-28
PL117466B1 (en) 1981-08-31
OA05643A (fr) 1981-04-30
RO72831A (ro) 1983-08-03
FR2348925B1 (enExample) 1980-04-11
YU104477A (en) 1983-01-21
FI63937C (fi) 1983-09-12
FI63937B (fi) 1983-05-31
FR2348925A1 (fr) 1977-11-18

Similar Documents

Publication Publication Date Title
US4233302A (en) Amine derivatives and pharmaceutical compositions containing them
US4279819A (en) Aminoalkyl furan derivatives
CA2436225C (en) N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
US4239769A (en) Pharmacologically active compounds
US6114334A (en) Piperazine derivatives as therapeutic agents
CA1190224A (en) Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists
US3686206A (en) Pyrazole and pyrazolone aminoketones
EP0183191B1 (en) Thienylthiazole compounds
IE62229B1 (en) 3-(4(1-Substituted-4-piperazinyl)butyl)-4-thiazoli dinones, a process for their preparation and their use as medicaments
US4123529A (en) Phenylpiperazine derivatives
GB1575904A (en) Phenyl piperazines
US3752810A (en) Substituted n aminoalkyl arylamino imidazolines-(2)
US3051707A (en) Unsymmetrical mono-(aminoalkylene)-hydrazines
US3311636A (en) Organic chemical compounds and process
KR840001775B1 (ko) 헤테로 사이클릭 유도체의 제조방법
EP0117345B1 (en) Aminopyrimidinones as histamine h2-antagonists
US4935424A (en) 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents
US4514408A (en) N-substituted nicotinamide 1-oxide as histamine H2 receptor blockers
US4169855A (en) N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine
CA1107285A (en) Arylaminoimidazoline derivatives and the preparation thereof
US4418079A (en) Conjugated ketone compounds in preventing platelet thrombosis
US3969351A (en) Morpholine containing isothiocyanobenzoxazoles
US2772276A (en) Basic esters of n-aryl-n-(heterocyclylalkyl) carbamic acids and syntheses thereof
EP0588850B1 (en) N-hydroxyurea derivatives which inhibit lipoxygenase
JPS61115074A (ja) ３，４‐ジアゾール誘導体、その製法、およびその化合物を含有する医薬品

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee